Caregiver Perspectives: The Cataldo Family, Primary Hyperoxaluria Type 1 (PH1)

  Рет қаралды 915

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Күн бұрын

This video was created for U.S. audiences.
The Cataldo family - mother Pat and brother Matthew discuss caregiving for John, who was diagnosed with primary hyperoxaluria type 1 (PH1) at age 4 and at age 27 went into kidney failure.
PH1 is an ultra-rare, life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 here: www.alnylam.com....
GO1-USA-00035

Пікірлер
The Skinner Family - Living with Primary Hyperoxaluria Type 1 (PH1)
2:17
Alnylam Pharmaceuticals
Рет қаралды 1,6 М.
Kim - Living with Primary Hyperoxaluria Type 1
3:39
Alnylam Pharmaceuticals
Рет қаралды 1 М.
Andro, ELMAN, TONI, MONA - Зари (Official Music Video)
2:50
RAAVA MUSIC
Рет қаралды 2 МЛН
요즘유행 찍는법
0:34
오마이비키 OMV
Рет қаралды 12 МЛН
Маусымашар-2023 / Гала-концерт / АТУ қоштасу
1:27:35
Jaidarman OFFICIAL / JCI
Рет қаралды 390 М.
УЛИЧНЫЕ МУЗЫКАНТЫ В СОЧИ 🤘🏻
0:33
РОК ЗАВОД
Рет қаралды 7 МЛН
Seth - Living with Primary Hyperoxaluria Type 1 (PH1)
2:54
Alnylam Pharmaceuticals
Рет қаралды 1,1 М.
PH1 of a Kind™ - Isabelle’s Story: Learning About PH1
2:03
Alnylam Pharmaceuticals
Рет қаралды 2,4 М.
Alicia - Living with Acute Hepatic Porphyria (AHP)
3:59
Alnylam Pharmaceuticals
Рет қаралды 260
Pathophysiology of Acute Hepatic Porphyria (AHP)
3:34
Alnylam Pharmaceuticals
Рет қаралды 1,1 М.
RNAi Therapeutics - How this New Class of Medicines Works
3:27
Alnylam Pharmaceuticals
Рет қаралды 772
RNAi, vielversprechendes Potenzial für eine neue Klasse von Medikamenten
3:32
Alnylam Pharmaceuticals
Рет қаралды 1 М.
Lernen Sie Alnylam kennen - ein führendes Unternehmen in RNAi-Therapeutika
3:05
Sue - Living with Acute Hepatic Porphyria (AHP)
4:05
Alnylam Pharmaceuticals
Рет қаралды 147
Alnylam Challengers Health Equity Symposium 2024
2:01
Alnylam Pharmaceuticals
Рет қаралды 682
Andro, ELMAN, TONI, MONA - Зари (Official Music Video)
2:50
RAAVA MUSIC
Рет қаралды 2 МЛН